Repository logo
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
    Communities & Collections
    Research Outputs
    Fundings & Projects
    People
    Organizations
    Statistics
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. College of Pharmacy / 藥學院
  3. School of Pharmacy / 藥學系
  4. 新穎時效控制性緩釋圓粒劑型之開發
 
  • Details
Options

新穎時效控制性緩釋圓粒劑型之開發

Other Title
Development of Novel Time-Controlled Sustained Release Pellet Dosage Forms
Type
report
Date Issued
2005
Author(s)
許明照
Subjects
藥學系
計畫報告
URI
https://203.71.86.71/handle/123456789/24391
File(s)
Loading...
Thumbnail Image
Name

attachment.pdf

Size

207.37 KB

Format

Adobe PDF

Checksum

(MD5):da708b50f0adfd76c3a3c7f31ad8586b

No Thumbnail Available
Name

attachment2.pdf

Size

0 B

Format

Adobe PDF

Checksum

(MD5):d41d8cd98f00b204e9800998ecf8427e

Copyright Notice

● The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use.

● Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner. Users must not use TMUIR for any illegal purposes.

● By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in this statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions.

● TMUIR is committed to protecting the interests of copyright owners. If you believe that any material on this website infringes copyright, please contact our staff at libirtmu@gmail.com, and we will remove the work from the repository.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback